In in vitro fertilization market report intra-cyto plasmic sperm injection segment accounted for largest share of global in vitro fertilization market, by technology, in 2016. Growing incidence of male infertility is contributing to large share of this segment. The embryo culture media accounted for largest share of global in vitro fertilization market, by reagents, in 2016 and is expected to grow at highest CAGR.
Complete report on In Vitro Fertilization Market spread across 159 Pages, Profiling 11 Companies and Supported with 100 Tables and 41 Figures is now available at www.reportsnreports.com/reports/63…cast-to-2021.html .
The in vitro fertilization market is projected to reach USD 756.7 Million by 2021 from USD 468.3 Million in 2016, at a CAGR of 10.1% during the forecast period. Both, top-down and bottom-up approaches were used to estimate and validate the size of the global market and to estimate the size of various other dependent submarkets in the overall in vitro fertilization market.
Target Audience for the Report
- Medical Device Industry
- Hospitals and Research Laboratories
- Academic Centers
- Fertility and Surgical Centers
In the coming years, APAC region is expected to witness highest growth rate in in vitro fertilization market.Factors like high maternal age in Japan, abolishment of China’s one child policy, rising fertility tourism in India and Thailand, growing surrogacy and high prevalence of PCOS in India and growing number of ART procedures in Australia and New Zealand are driving market in APAC region.
Major players in market are focusing on various strategies like agreements, alliances, collaborations, and partnerships; new product launches; acquisitions; product approvals; expansions; and other strategies (product enhancement and spin-off), to establish a strong foothold in global in vitro fertilization market.
2 Market Share Analysis
3 Coopersurgical, Inc. (A Subsidiary of Cooper Companies, Inc.)
4 Competitive Situation and Trends
5 New Product Launches
7 Agreements, Collaborations, Alliances, and Partnerships
8 Product Approvals
Cooper Surgical, Inc. (U.S.), Vitrolife AB (Sweden), Cook Medical, Inc. (U.S.), Irvine Scientific (U.S.), Thermo Fisher Scientific, Inc.
(U.S.), ESCO Micro Pte. Limited (Singapore), Genea Limited (Australia), The Baker Company (U.S.), IVFtech ApS (Denmark) and EMD Serono, Inc. (U.S.)are some of the key players in the global in vitro fertilization market.
By technology, in vitro fertilization market is categorized into intra-cytoplasmic sperm injection, pre-implantation genetic diagnosis, frozen embryo transplantation and others (assisted hatching, intrauterine insemination, donor insemination and in vitro maturation).
The intra-cytoplasmic sperm injection segment accounted for the largest share of the global market in 2016. Growing incidence of male infertility is contributing to the large share of this segment.